Home › Olfactory Esthesioneuroblastoma
Olfactory Esthesioneuroblastoma clinical trials recruiting in the U.S.
7 studies for Olfactory Esthesioneuroblastoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07527169Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
RecruitingPhase 2
Ages 18 to 120 · All sexes · Updated Nov 5, 2026 · NCT0617698968-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
RecruitingPhase 4
Ages 18 to 100 · All sexes · Updated Oct 30, 2026 · NCT04081701A Natural History Study of Children and Adults With Olfactory Neuroblastoma
RecruitingObservational study
Ages 3 to 120 · All sexes · Updated Oct 16, 2026 · NCT04755205Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Oct 6, 2026 · NCT06814496[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 6, 2026 · NCT06479811Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 28, 2025 · NCT00898638From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.